Eric Padron, MD, discusses the SRSF2 mutation in patients with MDS and CMML.
Eric Padron, MD
Advertisement
Articles by Eric Padron, MD
Advertisement
Latest Updated Articles
Dr. Padron on the SRSF2 Mutation in MDS and CMMLPublished: December 23rd 2013 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5